Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOVERS: Fluid Treatment Strategies in Sepsis-Induced Hypotension
NCT03434028Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of norepinephrine in septic shock, sponsored by Massachusetts General Hospital. Started Mar 2018; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03434028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434028.